Form 4: Pfizer SVP & Controller Jennifer B. Damico Reports Acquisition of Phantom Stock Units

Jennifer B. Damico, SVP & Controller at Pfizer Inc, reported the acquisition of 49 phantom stock units through the Pfizer Supplemental Savings Plan on March 28, 2024.

Summary

• On March 28, 2024, Jennifer B. Damico, SVP & Controller of Pfizer Inc, acquired 49 phantom stock units.
• The acquisition was made through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of common stock.
• The price of the phantom stock units was $27.75.
• Following the transaction, Damico directly owns 27,686 derivative securities.
• These units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.

Positives

• The acquisition of phantom stock units aligns Damico's interests with those of Pfizer's shareholders.
• The Pfizer Supplemental Savings Plan provides a mechanism for employees to accumulate wealth tied to the company's performance.

Future Outlook

The phantom stock units will be settled in cash upon Damico's separation from service or may be transferred to an alternative investment account.

Industry Context

Form 4 filings are standard practice for corporate insiders to report transactions in their company's securities, ensuring transparency and compliance with SEC regulations.

Comparison to Industry Standards

• Similar to other large publicly traded companies, Pfizer uses stock-based compensation plans like the Supplemental Savings Plan to incentivize and retain key employees.
• Companies like Johnson & Johnson and Merck also utilize similar deferred compensation and equity-based plans for their executives.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It provides transparency regarding insider transactions, which can be relevant to shareholders.

Key Dates